help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Liang, L.
Right arrow Articles by Frank, S. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Liang, L.
Right arrow Articles by Frank, S. J.
Endocrinology Vol. 141, No. 9 3328-3336
Copyright © 2000 by The Endocrine Society

ARTICLES

Insulin Receptor Substrate-1-Mediated Enhancement of Growth Hormone-Induced Mitogen-Activated Protein Kinase Activation1

Liang Liang, Jing Jiang and Stuart J. Frank

From the Department of Medicine, Division of Endocrinology and Metabolism (L.L., J.J., S.J.F.) and the Department of Cell Biology (S.J.F.), University of Alabama at Birmingham, and the Veterans Affairs Medical Center (S.J.F.), Birmingham, Alabama 35294

Address all correspondence and requests for reprints to: Stuart J. Frank, University of Alabama at Birmingham, Room 756, DERB UAB Station, 1808 7th Avenue South, Birmingham, Alabama 35294. E-mail: frank{at}endo.dom.uab.edu

Interaction of GH with the cell-surface GH receptor (GHR) causes activation of the GHR-associated tyrosine kinase, JAK2, and consequent triggering of signaling cascades including the STAT, Ras/Raf/MEK1/MAP kinase, and insulin receptor substrate-1(IRS-1)/PI3kinase pathways. We previously showed that IRS- and GHR-deficient 32D cells that stably express the rabbit GHR and rat IRS-1 (32D-rbGHR-IRS-1) exhibited markedly enhanced GH-induced proliferation and MAP kinase (ERK1 and ERK2) activation compared with cells expressing only the GHR (32D-rbGHR). We now examine biochemical mechanism(s) by which IRS-1 augments GH-induced MAP kinase activation. Time-course experiments revealed a similarly transient (maximal at 15 min) GH-induced ERK1 and ERK2 activation in both 32D-rbGHR and 32D-rbGHR-IRS-1 cells, but, consistent with our prior findings, substantially greater activation was seen in the IRS-1-containing cells. In both cells, GH-induced MAP kinase activation was markedly blunted by the MEK1 inhibitor, PD98059, but not by the PKC inhibitor, GF109203X. Interestingly, pretreatment with the PI3K inhibitor, wortmannin (EC50 ~ 10 nM), significantly reduced GH-induced MAP kinase activation in both 32D-rbGHR and 32D-rbGHR-IRS-1 cells. This same pattern in both cells of IRS-1-dependent augmentation and IRS-1-independent wortmannin sensitivity was also observed for GH-induced activation of Akt and MEK1 (using state-specific antibody blotting for both), despite the lack of difference in GHR, JAK2, SHP-2, p85, Akt, Ras, Raf-1, MEK1, ERK1, or ERK2 abundance between the two cells. A different PI3K inhibitor, LY294002 (50 µM), substantially inhibited (roughly 72%) GH-induced MAP kinase activation in 32D-rbGHR-IRS-1 cells, but only marginally (and statistically insignificantly) inhibited GH-induced MAP kinase activation in 32D-rbGHR cells. Because GH-induced Akt activation was completely inhibited in both cells by the same concentration of LY294002, these findings indicate that the wortmannin sensitivity of both the IRS-1-independent and -dependent GH-induced MAP kinase activation may reflect the activity of another wortmannin-sensitive target(s) in addition to PI3K in mediation of GH-induced MAP kinase activation in these cells. Notably, GH-induced STAT5 tyrosine phosphorylation, unlike Akt or MAPK activation, did not differ between the cells. Finally, while GH promoted accumulation of activated Ras in both cells, both basal and GH-induced activated Ras levels were greater in cells expressing IRS-1 than in 32D-rbGHR cells. These data indicate that while GH induces tyrosine phosphorylation of STAT5 and activation of the Ras/Raf/MEK1/MAPK and PI3K pathways, IRS-1 expression augments the latter two more than the former.




This article has been cited by other articles:


Home page
 J. Biol. Chem.Home page
D. J. DiGirolamo, A. Mukherjee, K. Fulzele, Y. Gan, X. Cao, S. J. Frank, and T. L. Clemens
Mode of Growth Hormone Action in Osteoblasts
J. Biol. Chem., October 26, 2007; 282(43): 31666 - 31674.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
M. Li, Z. Li, D. L. Morris, and L. Rui
Identification of SH2B2{beta} as an Inhibitor for SH2B1- and SH2B2{alpha}-Promoted Janus Kinase-2 Activation and Insulin Signaling
Endocrinology, April 1, 2007; 148(4): 1615 - 1621.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J. Xu, Z. Liu, T. L. Clemens, and J. L. Messina
Insulin Reverses Growth Hormone-induced Homologous Desensitization
J. Biol. Chem., August 4, 2006; 281(31): 21594 - 21606.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J. Xu, A. B. Keeton, J. L. Franklin, X. Li, D. Y. Venable, S. J. Frank, and J. L. Messina
Insulin Enhances Growth Hormone Induction of the MEK/ERK Signaling Pathway
J. Biol. Chem., January 13, 2006; 281(2): 982 - 992.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
N. Yang, Y. Huang, J. Jiang, and S. J. Frank
Caveolar and Lipid Raft Localization of the Growth Hormone Receptor and Its Signaling Elements: IMPACT ON GROWTH HORMONE SIGNALING
J. Biol. Chem., May 14, 2004; 279(20): 20898 - 20905.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
M. D. Lewis, M. Horan, D. S. Millar, V. Newsway, T. E. Easter, L. Fryklund, J. W. Gregory, M. Norin, C.-J. Del Valle, J. P. Lopez-Siguero, et al.
A Novel Dysfunctional Growth Hormone Variant (Ile179Met) Exhibits a Decreased Ability to Activate the Extracellular Signal-Regulated Kinase Pathway
J. Clin. Endocrinol. Metab., March 1, 2004; 89(3): 1068 - 1075.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
Y. Huang, S.-O. Kim, J. Jiang, and S. J. Frank
Growth Hormone-induced Phosphorylation of Epidermal Growth Factor (EGF) Receptor in 3T3-F442A Cells: MODULATION OF EGF-INDUCED TRAFFICKING AND SIGNALING
J. Biol. Chem., May 23, 2003; 278(21): 18902 - 18913.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
J. A. Bush, S. R. Kimball, P. M. J. O'Connor, A. Suryawan, R. A. Orellana, H. V. Nguyen, L. S. Jefferson, and T. A. Davis
Translational Control of Protein Synthesis in Muscle and Liver of Growth Hormone-Treated Pigs
Endocrinology, April 1, 2003; 144(4): 1273 - 1283.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
S.-O. Kim, K. Loesch, X. Wang, J. Jiang, L. Mei, J. M. Cunnick, J. Wu, and S. J. Frank
A Role for Grb2-Associated Binder-1 in Growth Hormone Signaling
Endocrinology, December 1, 2002; 143(12): 4856 - 4867.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S. Ji, S. J. Frank, and J. L. Messina
Growth Hormone-induced Differential Desensitization of STAT5, ERK, and Akt Phosphorylation
J. Biol. Chem., August 9, 2002; 277(32): 28384 - 28393.
[Abstract] [Full Text] [PDF]

Home page
 Exp. Biol. Med.Home page
F. P. Dominici and D. Turyn
Growth Hormone-Induced Alterations in the Insulin-Signaling System
Experimental Biology and Medicine, March 1, 2002; 227(3): 149 - 157.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2000 by The Endocrine Society